中国临床解剖学杂志 ›› 2024, Vol. 42 ›› Issue (1): 47-53.doi: 10.13418/j.issn.1001-165x.2024.1.09

• 实验研究 • 上一篇    下一篇

依达拉奉经MAPKs通路对脂多糖激活的小胶质细胞Sirt3表达调控

祁志#,    杨力#,    贾秋叶,    陈浩伦,    段兆达,    吴春云*   

  1. 昆明医科大学基础医学院人体解剖与组织胚胎学系,  昆明    650500
  • 收稿日期:2023-05-05 出版日期:2024-01-25 发布日期:2024-01-30
  • 通讯作者: 吴春云,教授,博士生导师, E-mail:wuchunyunkm@163.com
  • 作者简介:祁志(2000-),男,临床医学本科在读,E-mail:1633690688@qq.com;共同第一作者:杨力(1976-),男,博士研究生,研究方向:神经退变机制,E-mail:yanglikm@163.com
  • 基金资助:
    国家自然科学基金(81960223);云南省科技厅昆明医科大学联合专项(202301AY070001-163);云南省大学生创新性实验计划项目;昆明医科大学大学生创新性实验计划项目(2022JXD301)

Edaravone regulates Sirt3 expression in lipopolysaccharide-activated microglia via MAPKs signaling pathway

Qi Zhi#, Yang Li#, Jia Qiuye, Chen Haolun, Duan Zhaoda, Wu Chunyun*   

  1. Department of Human Anatomy and Tissue Embryology, School of Basic Medical Sciences, Kunming Medical University, Kunming 650500, China
  • Received:2023-05-05 Online:2024-01-25 Published:2024-01-30

摘要: 目的    探究依达拉奉对LPS激活的小胶质细胞Sirt3和MAPKs通路相关蛋白的作用及其调控机制。  方法    采用Western blot和免疫荧光双标染色检测LPS激活的BV2小胶质细胞中Sirt3和MAPKs通路相关蛋白ERK1/2、P38、JNK及p-ERK1/2、p-P38和p-JNK的表达;检测ERK1/2通路抑制剂处理后p-ERK1/2和Sirt3的表达。  结果    LPS激活的BV细胞中Sirt3、p-ERK1/2、p-P38和p-JNK表达显著增高,依达拉奉能促进Sirt3和p-ERK1/2过表达,并降低p-P38和p-JNK表达;ERK1/2抑制后p-ERK1/2和Sirt3的蛋白表达降低。依达拉奉可促进激活的BV2细胞中Sirt3和p-ERK1/2过表达,并下调过表达的p-P38和p-JNK。  结论    依达拉奉可调节BV2细胞中MAPKs信号通路并促进Sirt3生成,可能经ERK/Sirt3通路发挥抗炎作用。

关键词: 依达拉奉; ,  , Sirt3; ,  , 小胶质细胞; ,  , MAPKs信号通路

Abstract: Objective   To investigate the effect of edaravone on Sirt3 and MAPKs pathway-related proteins in LPS-activated microglia and its regulatory mechanism. Methods  Western Blot and immunofluorescence were used to detect the effect of edaravone on the protein expression of Sirt3 and MAPKs pathway-related proteins ERK1/2, P38, JNK as well as their phosphorylated forms p-ERK1/2, p-P38 and p-JNK in the activated BV2 cells. Western Blot techniques were applied to detect the effects of ERK1/2 pathway inhibitor on the expressions of p-ERK1/2 and Sirt3.   Results   The expressions of Sirt3, p-ERK1/2, p-P38 and p-JNK in microglia were significantly increased after BV2 cells activation. Edaravone promoted the expression of Sirt3 and p-ERK1/2 and downregulated the expression of p-JNK and p-P38. The protein expression of Sirt3 and p-ERK1/2 decreased after co-treatment with edaravone and ERK1/2 inhibitor. Edaravone promoted the overexpression of Sirt3 and p-ERK1/2 and downregulated the expression of p-JNK and p-P38. Conclusions    Edaravone can regulate MAPKs signaling pathway and promote Sirt3 production in BV2 cells, possibly regulates neuroinflammatory responses via ERK/Sirt3 signaling pathway.

Key words: Edaravone; ,  , Sirt3; ,  , Microglia; ,  , MAPKs signaling pathway

中图分类号: